112578 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
Method and device for monitoring platelet function
#302Methods and compositions for protection against thrombolysis associated reperfusion injury
#303Method for determining percent platelet aggregation
#304Hematological assay and kit
#305Device for aggregating, imaging and analyzing thrombi and a method of use
#3062-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
#307Assessment of cardiac health and thrombotic risk in a patient
#308Coagulation and fibrinolytic cascades modulator
#309Methods for detecting TAFIa or TAFIai
#310Stable chromogenic test reagent and its use in coagulation-diagnostic tests
#311Assay for tissue factor in a sample
#312Substrates for TAFI (A)
#313Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media
#314Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
#315Methods of treating peripheral arterial occlusions
#316Variants of factor XllA
#317Crystal structure of factor Vai and method for identifying blood factor Va modulators
#318Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
#319Compositions, kit and one-step method for monitoring compounds having anti-factor Xand/or anti factor IIactivities
#320Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds
#321Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
#322Protease for activating clotting factor VII
#323Process and device for determining viscosity
#324Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences
#325Pharmaceutical preparation with RNA as hemostasis cofactor
#326Screening method for agents useful in treating diabetes
#327Protocol and apparatus for determining heparin-induced thrombocytopenia
#328Early detection of pathogens in blood
#329Method for determining the biological activity of defibrotide